The latest from Xeomics
Company news and perspectives on genomics, precision medicine, AI and global health equity.
InsightsAI will augment, not replace, doctors
Dr. George Zarkadakis, writing in Re:solve Global Health: generative AI is moving medicine toward general medical intelligence — and diverse data and sound governance will decide who benefits.
Read the article →[Working title] Real-world data and evidence from the populations trials leave out
First piece in the RWD/RWE track by Sue Beecroft. Publishing on her return; will also be linked from the Syntium pages.
The 2,000-year history of AI: George Zarkadakis on History Uncensored
Video · 45 min. Our Chief Innovation Officer joins Bianca Nobilo to trace the thinking machine from Talos to Turing.
Watch → InsightsWhy Africa’s Genomic Future Matters to the World
Africa holds the greatest human genetic diversity on Earth — yet it remains dramatically underrepresented in genomics.
Read → NewsXeomics joins the Global Alliance for Genomics & Health (GA4GH)
Now an Organizational Member of GA4GH — a milestone in our mission to advance responsible genomics and global health-data innovation.
Read → InsightsGene therapies: why lowering costs depends on AI and data diversity
By Dr. George Zarkadakis. Gene therapies have moved from science fiction to clinical reality — yet the cost remains staggering.
Read → NewsAmplifier Health partners with Xeomics to scale voice biomarker technology
A strategic partnership to advance healthcare diagnostics through pioneering voice-based acoustic models.
Read → InsightsUnlocking personalized medicine through pharmacogenomics
Imagine a world where your doctor prescribes medication tailored specifically to your DNA. That is the promise of pharmacogenomics.
Read → InsightsDiverse global clinical datasets are critical for the future of drug research
Drug discovery too often relies on data drawn from predominantly white populations — limiting how well conclusions generalize to the majority of humanity.
Read →No articles in this category yet.
Stay close to the work
Request a briefing for the latest on our platform, partnerships and national programs.